# A Study of Meropenem Standard 30 Minute Infusion Versus Prolonged 3 Hour Infusion in Intensive Care Unit (ICU) Patients

> **NCT00891423** · NA · COMPLETED · sponsor: **Austin Health** · enrollment: 10 (actual)

## Conditions studied

- Sepsis

## Interventions

- **DRUG:** Meropenem short infusion
- **DRUG:** Meropenem extended infusion

## Key facts

- **NCT ID:** NCT00891423
- **Lead sponsor:** Austin Health
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2010-01
- **Final completion:** 2010-01
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2015-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00891423

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00891423, "A Study of Meropenem Standard 30 Minute Infusion Versus Prolonged 3 Hour Infusion in Intensive Care Unit (ICU) Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00891423. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*